WHO Prequalification
WHO Prequalification is a programme by the World Health Organization. It assesses the quality, safety, and efficacy of medicines and vaccines. The aim is to ensure that essential health products meet international standards. This process supports global health initiatives. It also facilitates access to vital treatments in low- and middle-income countries. Prequalified products gain trust and recognition worldwide.
The World Health Organization granted prequalification on 24 April 2026 to the first malaria treatment specifically designed for newborns and young infants. The medicine is artemether-lumefantrine, marketed as...
April 25, 2026